Experience

A fine
balance

The passion you want at your side, plus the experience you want at the table.

Meet Our Team

Team

Greater perspectives create greater outcomes.

Balance, diversity and passion are at the core of who we are. Meet the hardworking people who defy convention, shatter glass ceilings, and take companies to the top—all with a unique style and a healthy dose of humor.

Companies

A dynamic
portfolio

Across healthcare and technology, we partner with companies that improve lives.

See Our Companies

Companeis

The future looks bright.

Say hello to our extended family. An impressive roster of agile and imaginative companies that are building the future of healthcare and technology, one big idea at a time. Our portfolio of entrepreneurial muscle includes 59 IPOs and 134 M&As. And counting.

Approach

A hand
in every stage

From the first handshake to the final round, we do what it takes to bring your vision to life.

Learn About Our Approach

About

This is Canaan.

Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas. While we love speedy success, we’re acutely aware that greatness comes in many forms and at different times. That’s why we’re not afraid to break the mold to bring something spectacular to life.

Experience

A fine
balance

>Berkshire Grey

The passion you want at your side, plus the experience you want at the table.

Meet Our Team

Companies

A dynamic
portfolio

>IDEAYA Biosciences

Across healthcare and technology, we partner with companies that improve lives.

See Our Companies

Approach

A hand
in every stage

>Turo

From the first handshake to the final round, we do what it takes to bring your vision to life.

Learn About Our Approach
Highlight

Washington Post: As millions of dollars pour in, esports teams offer varying visions of the future

In a departure from traditional sports, Gen.G will not only be looking to attract top players, but top content creators as well, since they plan to...
Highlight

STAT News: Arrakis' lofty goal: Kill cancer with pills that target RNA instead of proteins

The startup is trying to achieve a feat once thought to be biotech fantasy: Develop oral medicines - pills - that can target RNA, the...
Highlight

Forbes: Is Silicon Valley coming for rosé?

Bev, a female-focused beverage company disrupting the male-dominated alcohol industry, has raised $7 million.
Highlight

Reuters: Aeva signs sensor deal with Audi's self-driving unit

Aeva has signed a sensor-system deal with an Audi-owned unit that is working on self-driving technology for Volkswagen AG.